Onset of lichen planopilaris during treatment with etanercept

British Journal of Dermatology

Volumn 158, Issue 5, 2008, Pages 1161-1163

  Garcovich, S ^a   Manco, S ^a   Zampetti, A ^a   Amerio, P ^a   Garcovich, A ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Cutaneous adverse reaction; Etanercept; Lichen

Indexed keywords

BETAMETHASONE; CYCLOSPORIN A; ETANERCEPT; ETORICOXIB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ALOPECIA; CASE REPORT; CLINICAL FEATURE; DARIER DISEASE; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; HAIR LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LICHEN; LICHEN PLANOPILARIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RECURRENT DISEASE; SCALP; SKIN BIOPSY; SKIN PAIN; SKIN PRURITUS;

ARTHRITIS, PSORIATIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 42049113646     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08529.x     Document Type: Letter

References (10)

1. Gottlieb AB, Leonardi CL, Goffe BS et al. Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an integrated multistudy database. J Am Acad Dermatol 2006 3 (Suppl. 2 S92 100.
2. Lee HH, Song IH, Friedrich M et al. Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists. Br J Dermatol 2007 156 : 486 91.
3. Posten W, Swan J. Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol 2005 141 : 759 60.
4. Tong X, Coulombe PA. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev 2006 15 : 1353 64.
5. Vergara G, Silvestre JF, Betlloch I et al. Cutaneous drug eruption to infliximab: report of 4 cases with an interface dermatitis pattern. Arch Dermatol 2002 138 : 1258 9.
6. Soliotis F, Glover M, Jawad ASM. Severe skin reaction after leflunomide and etanercept in a patient with rheumatoid arthritis. Ann Rheum Dis 2002 61 : 850 1.
7. Fischer M, Fiedler E, Marsch WC et al. Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis. Br J Dermatol 2002 146 : 707 9.
8. Hunger RE, Hunziker T, Buettiker U et al. Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment. J Allergy Clin Immunol 2005 116 : 923 4.
9. Chieregato C, Zini A, Barba A et al. Lichen planopilaris: report of 30 cases and review of the literature. Int J Dermatol 2003 42 : 342 5.
10. Beuthien W, Mellinghoff H-U, Von Kempis J. Skin reaction to adalimumab. Arthritis Rheum 2004 50 : 1690 2.